Loading...
Colchicine for COVID-19: Evidence review of the clinical benefit and harm
Blockman, M Cohen, K De Waal, R Gray, A Kredo, T Maartens, G Nel, J Rees, H Parrish, A Reubenson, G
Blockman, M
Cohen, K
De Waal, R
Gray, A
Kredo, T
Maartens, G
Nel, J
Rees, H
Parrish, A
Reubenson, G
Citations
Altmetric:
Abstract
Description
Colchicine is an anti-inflammatory drug that is used to treat a variety of conditions, including gout, recurrent pericarditis, and familial Mediterranean fever.1 Recently, the drug has been shown to potentially reduce the risk of cardiovascular events in those with coronary artery disease
Date
2020-10-20
Journal Title
Journal ISSN
Volume Title
Publisher
South African National Department of Health
Collections
Files
Loading...
Colchicine for COVID-19
Adobe PDF, 396.17 KB
Research Projects
Organizational Units
Journal Issue
Keywords
Colchicine, Anti-inflammatory drug, Rapid review, Treatment for COVID-19 for patients
Citation
Blockman M, Cohen K, De Waal R, Gray A, et al. Colchicine for COVID-19: evidence review of the clinical benefit and harm. South African National Department of Health; 20 October 2020.
License
Attribution 3.0 United States